Physician profile
Julie E Breen
NPI 1407279631
$2,615.26
in general payments reported to CMS, 2019-2025
25 companies · $27.99 in 2025
The $27.99 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,462 · 2022: $941 · 2024: $184 · 2025: $27.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $882.32 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $564.46 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $165.79 | 2021-2022 | |
| Saluda Medical Americas, INC. | $159.38 | 2024 | Evoke |
| Arbor Pharmaceuticals, INC. | $139.62 | 2021 | |
| Grt US Holding, INC. | $124.18 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $89.26 | 2021-2022 | |
| Spr Therapeutics, INC | $56.58 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $51.62 | 2021 | |
| Tersera Therapeutics LLC | $50.72 | 2021-2022 | |
| Almatica Pharma LLC | $46.93 | 2021 | |
| Redhill Biopharma INC. | $38.11 | 2021 | |
| Biodelivery Sciences International, INC. | $36.14 | 2021 | |
| Janssen Biotech, INC. | $27.99 | 2025 | Tremfya |
| Abbott Laboratories | $24.55 | 2024 | Octrode |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $20.75 | 2021 | |
| Nevro Corp. | $19.64 | 2022 | |
| Virtus Pharmaceuticals LLC | $18.41 | 2021 | |
| Ibsa Pharma INC. | $15.40 | 2021 | |
| Stimwave Technologies Incorporated | $15.00 | 2022 | |
| Azurity Pharmaceuticals, INC. | $14.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2022 | |
| Vertos Medical, INC. | $14.60 | 2021 | |
| Allergan, INC. | $12.51 | 2021 | |
| Pfizer INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.